Editor and Publisher ... Henry enters his twelve (12) year at RegMed Investors which aggregates, curates and creates bottom-line content of regenerative medicine and cell therapy news providing a "vetted" selection of relevant and high-impact synthesis. He was VP - Strategic Planning... More
Instablogged StocksStocks that instabloggers have most recently written about
- 1 Biotech Momentum Indicators: Achaogen (AKAO)...
- 2 Micro-Cap Opportunity: Why Does 3PEA Interna...
- 3 Is BHO & Washington Working For Iran?
- 4 Intermediate Trend: Short Euro And Gold
- 5 Gold And Silver Outlook For March 30- April 3
- See all Top Instablogs »